Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Identify which index funds yield the strongest after-tax returns in 2024. Learn how tax considerations impact fund performance and retirement strategy.
27,937 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
Bitcoin’s on-chain data is flashing a capitulation warning as holders pull liquidity and BTC trades in the mid-60s. A...
A major 30% drop in Coinbase shares has analysts looking beyond the move. They’re focusing on Bitcoin trends, Coinbas...
Six sectors are signaling strong hiring for today’s graduates. A new market analysis highlights healthcare, software,...
Navan stock soared today as the company posted solid growth and highlighted AI-driven efficiencies in its platform. T...
Qualcomm sits at a critical crossroads in the semiconductor world, with strong fundamentals and steady cash flow. Thi...
Rocket Lab isn’t profitable yet, but the space company shows four clear catalysts for investors. Here are practical r...
Investors chasing AI growth need to connect revenue signals to real opportunity. This analysis compares Astera Labs a...
Could Zcash flip Bitcoin? This article breaks down how Zcash’s privacy features, regulatory dynamics, and market tren...
A 2025 performance-year pay surge pushed the average wall street bonus to around $210,000, about three times the typi...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...